Related Experiment Video
Updated: Jun 17, 2026
04:33
Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Does effective management of sleep disorders reduce substance dependence?
1Sleep Disorders and Research Center, Henry Ford Health System, Detroit, Michigan 48202, USA. troth1@hfhs.org
Drugs
|January 6, 2010
Summary
Treating insomnia may help reduce substance dependence and relapse risk. However, more research is needed to confirm if insomnia interventions effectively prevent relapse in individuals with substance use disorders.
Area of Science:
- Sleep Medicine
- Addiction Psychiatry
- Psychopharmacology
Background:
- Insomnia is frequently linked to substance dependence, affecting individuals with nicotine, alcohol, and illicit drug abuse.
- Sleep disturbances and insomnia are common during withdrawal from various substances, potentially increasing relapse risk.
- Existing insomnia treatments show efficacy for withdrawal-related sleep issues, but their impact on relapse prevention remains unclear.
Purpose of the Study:
- To evaluate the potential of effective sleep disorder management in reducing substance dependence and relapse rates.
- To review existing literature on the efficacy of insomnia treatments in substance-dependent populations.
- To identify knowledge gaps regarding the impact of insomnia interventions on relapse in abstinent individuals.
Main Methods:
- A targeted literature review was conducted following a 2008 workshop on sleep disorders and substance dependence.
- The review focused on data evaluating whether pharmacological or cognitive behavioral treatments for insomnia could reduce relapse risk.
- Analysis of existing research to assess the effectiveness of insomnia management in substance-dependent patients.
Main Results:
- Substantial data supporting the reduction of relapse risk through pharmacological or cognitive behavioral treatment of insomnia in substance dependence was lacking.
- Evidence regarding the effect of insomnia treatment on nicotine withdrawal and relapse prevention is limited.
- The review highlighted a need for further research into the impact of insomnia on substance dependence and relapse.
Conclusions:
- Current evidence is insufficient to definitively conclude that insomnia treatment reduces relapse risk in substance dependence.
- Further research is required to understand the complex relationship between insomnia, substance dependence, and relapse.
- Investigating the role of insomnia interventions in preventing relapse is crucial for improving patient outcomes.
More Related Videos
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
Related Concept Videos
01:24Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:13Insufficient Sleep and Sleep Deprivation
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...